Vanessa van Empel

Associate professor

Dr Vanessa van Empel studied Medicine at the University of Maastricht. During her studies, she started her PhD on the topic heart failure. She obtained her PhD from the University of Utrecht in 2007. Subsequently she started her training as a cardiologist at the Maastricht University Medical Centre. After finishing her cardiology training in 2011, Vanessa was rewarded the ICIN fellowship, which enabled her to do a post-doctoral fellowship at the Alfred Hospital in Melbourne, Australia, where she gained more expertise in the field of heart failure with preserved ejection fraction (HFpEF). She now is a staff member at the Maastricht UMC+ with an expertise in heart failure, and heart failure with preserved ejection fraction specifically.

Her clinical work and research has been dedicated to HFpEF. She initiated the HFpEF clinic in Maastricht, which started in 2015, and is responsible for the Maastricht HFpEF cohort. She obtained a grant 'Vrouwelijk Hartfalen' from the Health Foundation Limburg together with Prof. Blanche Schroen, is co-PI on the CVON project Early detection of HFpEF and is project leader of the CVON SHE-PREDICT-HF, which studies sex differences in HFpEF. These projects allow her to continue her research on HFpEF with special focus on cardiovascular imaging, biomarkers and microvascular dysfunction.

Department of Cardiology
P. Debeyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht
Room number: Maastricht UMC+ level 3
T: +31(0)43 387 70 95

  • 2020
    • Suthahar, N., Meems, L. M. G., van Veldhuisen, D. J., Walter, J. E., Gansevoort, R. T., Heymans, S., Schroen, B., van der Harst, P., Kootstra-Ros, J. E., van Empel, V., Mueller, C., Bakker, S. J. L., & de Boer, R. A. (2020). High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men. Mayo Clinic Proceedings, 95(6), 1158-1168. https://doi.org/10.1016/j.mayocp.2020.01.017
    • Verdonschot, J. A. J., Merken, J. J., Brunner-La Rocca, H-P., Hazebroek, M. R., Eurlings, C. G. M. J., Thijssen, E., Wang, P., Weerts, J., van Empel, V., Schummers, G., Schreckenberg, M., van den Wijngaard, A., Lumens, J., Brunner, H. G., Heymans, S. R. B., Krapels, I. P. C., & Knackstedt, C. (2020). Value of Speckle Tracking-Based Deformation Analysis in Screening Relatives of Patients With Asymptomatic Dilated Cardiomyopathy. JACC-Cardiovascular Imaging, 13(2), 549-558. https://doi.org/10.1016/j.jcmg.2019.02.032
  • 2019
    • Gingele, A. J., Ramaekers, B., Brunner-La Rocca, H. P., De Weerd, G., Kragten, J., van Empel, J. M., van der Weg, K., Vrijhoef, H. J. M., Gorgels, A., Cleuren, G., Boyne, J. J. J., & Knackstedt, C. (2019). Effects of tailored telemonitoring on functional status and health-related quality of life in patients with heart failure. Netherlands Heart Journal, 27(11), 565-574. https://doi.org/10.1007/s12471-019-01323-x
    • Simonavicius, J., Van-Wijk, S. S., Rickenbacher, P., Maeder, M. T., Pfister, O., Kaufmann, B. A., Pfisterer, M., Celutkiene, J., Puronaite, R., Knackstedt, C., van Empel, V., & Brunner-La Rocca, H-P. (2019). Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF Trial. American Journal of Medicine, 132(9), E679-E692. https://doi.org/10.1016/j.amjmed.2019.04.010
    • Gingele, A. J., Brunner-la Rocca, H., Ramaekers, B., Gorgels, A., De Weerd, G., Kragten, J., van Empel, V., Brandenburg, V., Vrijhoef, H., Cleuren, G., Knackstedt, C., & Boyne, J. J. J. (2019). Telemonitoring in patients with heart failure: Is there a long-term effect?Journal of Telemedicine and Telecare, 25(3), 158-166. https://doi.org/10.1177/1357633X17747641
    • Beale, A. L., Nanayakkara, S., Segan, L., Mariani, J. A., Maeder, M. T., van Empel, V., Vizi, D., Evans, S., Lam, C. S. P., & Kaye, D. M. (2019). Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology A Detailed Invasive Hemodynamic and Echocardiographic Analysis. JACC-Heart Failure, 7(3), 239-249. https://doi.org/10.1016/j.jchf.2019.01.004
  • 2018
    • Aizpurua, A. B., Schroen, B., van Bilsen, M., & van Empel, V. (2018). Targeted HFpEF therapy based on matchmaking of human and animal models. American Journal of Physiology-heart and Circulatory Physiology, 315(6), H1670-H1683. https://doi.org/10.1152/ajpheart.00024.2018
    • van Empel, V., & Brunner-La Rocca, H-P. (2018). Helping to understand heart failure with preserved ejection fraction. European Heart Journal, 39(30), 2836-2838. https://doi.org/10.1093/eurheartj/ehy368
    • Suthahar, N., Meijers, W. C., Ho, J. E., Gansevoort, R. T., Voors, A. A., van der Meer, P., Bakker, S. J. L., Heymans, S., van Empel, V., Schroen, B., van der Harst, P., van Veldhuisen, D. J., & de Boer, R. A. (2018). Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population. European journal of heart failure, 20(8), 1205-1214. https://doi.org/10.1002/ejhf.1209
    • Rech, M., Aizpurua, A. B., van Empel, V., van Bilsen, M., & Schroen, B. (2018). Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle. Cardiovascular Research, 114(6), 782-793. https://doi.org/10.1093/cvr/cvy049